Advisory Board

The Advisory Board of the Department of Bioengineering consists of a select group of industrial leaders and academic representatives who are primarily alumni of the department or members of its constituent groups. They have shown leadership and professional success in their career and are fully dedicated to helping Clemson University develop and maintain highly competitive research and educational programs in bioengineering.

Members of the Advisory Board partner with the Chair of the Department of Bioengineering and are appointed for a three-year term. Following a term, members can be reappointed annually at the discretion of the Chair. A maximum of 15 members will serve on the Board at any given time. Membership representation shall reflect the bioengineering profession.

Current Members

Stephen Ainsworth*
Executive Vice President of Strategy & Technology, ChoiceSpine

Andrew Cobb* 
Medtronic

Rebecca DeLegge*, (Chair)
CEO and Founder, DeLegge Medical

Mike Gara
Principal with Equinox Medtech Partners

John Gilpin 
Diagnostic Radiology, Prisma Health

Andrew Green* 
EVP and General Manager of Cardiovascular Products at Aziyo Biologics, Inc.

Harry Thomas Hall I.V.*
Global Orthopaedic Franchise Leader, Trauma, Craniomaxillofacial, and Veterinary for Depuy Synthes

Steve Johnson
Investment Manager, SCRA

Kim P. Kelly*
Director, Regulatory Affairs, Bioventus

Eugene M. Langan, III
Chairman Emeritus, Department of Surgery, Greenville Health System

Marc Long*
VP Research and Development, Musculoskeletal Transplant Foundation

Joshua Lovekamp*
Business Unit Leader, W.L. Gore & Associates, Inc.

Robert J. Morff
Venture Partner, Hatteras Venture Partners

David Shalaby 
President, Poly-Med, Inc.

Jennifer Woodell-May*
Program Director, Advanced Osteoarthritis Therapies, Zimmer Biomet

* Clemson Bioengineering Alumnus